1996
DOI: 10.1128/aac.40.2.279
|View full text |Cite
|
Sign up to set email alerts
|

Antifungal agents: chemotherapeutic targets and immunologic strategies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
225
0
1

Year Published

1996
1996
2015
2015

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 445 publications
(229 citation statements)
references
References 297 publications
(252 reference statements)
0
225
0
1
Order By: Relevance
“…One reason for the slow progress compared to antibacterials is that, like mammalian cells, fungi are eukaryotes; and therefore agents that inhibit protein, RNA or DNA biosynthesis in fungi have greater potential for toxicity to the host as well (Georgopapadakou and Walsh 1994). The second reason is that, until recently, the incidence of life-threatening fungal infections was perceived as being too low to warrant aggressive research by the pharmaceutical companies (Georgopapadakou and Walsh 1996).…”
Section: Historical Backgroundmentioning
confidence: 99%
See 4 more Smart Citations
“…One reason for the slow progress compared to antibacterials is that, like mammalian cells, fungi are eukaryotes; and therefore agents that inhibit protein, RNA or DNA biosynthesis in fungi have greater potential for toxicity to the host as well (Georgopapadakou and Walsh 1994). The second reason is that, until recently, the incidence of life-threatening fungal infections was perceived as being too low to warrant aggressive research by the pharmaceutical companies (Georgopapadakou and Walsh 1996).…”
Section: Historical Backgroundmentioning
confidence: 99%
“…New targets actively pursued in the ergosterol biosynthesis pathway are oxidosqualene cyclase and v 24 methyl transferase. The latter has no mammalian counterpart (cholesterol is not methylated at C-24) and is thus a particularly attractive target (Oehlschlager and Czyzewska 1992;Georgopapadakou and Walsh 1996).…”
Section: New Targets For Novel Antimycoticsmentioning
confidence: 99%
See 3 more Smart Citations